Characterization of the Pathogen Distribution and Drug Resistance in Bloodstream Infections During COVID-19 Pandemic in a Tertiary Hospital in Eastern China: Comparison with the Pre-Pandemic Period
Min Gu,Xiaohui Zhang,Fang Ni,Jue Wang,Wenying Xia,Yanfei Lu
DOI: https://doi.org/10.2147/idr.s476267
2024-08-27
Infection and Drug Resistance
Abstract:Min Gu, 1, 2, &ast Xiaohui Zhang, 1, 2, &ast Fang Ni, 1, 2 Jue Wang, 1, 2 Wenying Xia, 1, 2 Yanfei Lu 1, 2 1 Department of Laboratory Medicine, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, People's Republic of China; 2 National Key Clinical Department of Laboratory Medicine, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yanfei Lu; Wenying Xia, Department of Laboratory Medicine, Jiangsu Province Hospital, Street No. 300, Guangzhou, 210029, People's Republic of China, Tel +8625-6830-6287, Email ; Purpose: To explore the characteristics of the pathogen distribution and drug resistance in bloodstream infections (BSIs) during the COVID-19 pandemic in a tertiary hospital in eastern China, and to compare them with those before the pandemic. Patients and Methods: Non-repetitive strain data of BSIs were retrospectively obtained before the COVID-19 pandemic (Pre-Pandemic, n=2698) and during the COVID-19 pandemic (Pandemic, n=2922), the distribution of pathogens and drug resistance were compared between the two groups. Results: The main pathogens of BSIs were Gram-negative bacteria (57.91%), followed by Gram-positive bacteria (32.58%), fungi and anaerobic bacteria accounting for 5.48% and 3.39%, respectively. Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus were the top 3 isolates. The proportion of Serratia marcescens, Enterobacter aerogenes, Enterococcus faecium, Enterococcus faecalis and Candida tropicalis were significantly increased, while those of Pseudomonas aeruginosa, Streptococcus sanguinis and Streptococcus pneumoniae were significantly decreased when compared to the Pre-Pandemic ( P < 0.05). Carbapenem-resistant Enterobacterales (CRE) significantly elevated during the Pandemic (17.4% vs 14.4%, P =0.041); the detection of carbapenem-resistant Pseudomonas aeruginosa (CRPA) significantly ascended (39.0% vs 24.4%, P =0.016); and the proportion of carbapenem-resistant Acinetobacter baumannii (CRAB) maintained stable (78.8%). Gram-positive bacteria had the lowest resistance to linezolid, vancomycin and tigecycline, which remained a stable trend with the Pre-Pandemic (< 5.0%). The isolate rates of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) were 38.9% and 1.0%, respectively. Staphylococcus aureus showed a decrease in the isolation rate of vancomycin minimum inhibitory concentration (MIC) ≤ 0.5 μg/mL ( χ 2 =7.676, P =0.006) and an increase with vancomycin MIC=1 μg/mL ( χ 2 =9.008, P =0.003). Conclusion: The pathogen distribution and drug resistance of BSIs during the COVID-19 pandemic were transformed from Pre-Pandemic and accompanied by increasing bacterial resistance. Clinical management of antibiotic application and infection control should be strengthened. Keywords: COVID-19 pandemic, bloodstream infection, pathogen distribution, antibiotic resistance Bloodstream infections (BSIs) are frequent life-threatening infectious diseases clinically, the incidence of which is approximately 113–204 per 100,000 population, similar to that of stroke or venous thrombosis. 1 The disease has a mortality rate of 18%-35% 2 and may contribute to prolonged hospitalizations and severe complications, imposing a heavy burden on patients and healthcare systems. 3,4 Due to the widespread application of modern invasive diagnostic and therapeutic technologies and the inappropriate use of antibiotics, the incidence rate of BSIs has been increasing. 5 Antibiotic therapy is an effective method for BSIs, and timely control of BSIs is crucial for patients' prognosis. Blood culture is currently the gold standard for diagnosing BSIs. 6 Clinicians typically choose broad-spectrum antibiotics empirically based on the blood culture results and then adjust the type and dosage of antibiotics according to antimicrobial susceptibility testing in vitro. 7 The distribution of pathogen and drug resistance in patients with BSIs has general heterogeneity. Therefore, understanding the distribution of pathogenic bacteria and drug resistance characteristics of BSIs in different periods, regions, and even populations is essential for empirical therapy and antibiotic management. Coronavirus disease 2019 (COVID-19) is an aggressive respiratory infectious disease caused by the novel severe acute respirator -Abstract Truncated-
pharmacology & pharmacy,infectious diseases